Gene therapy is showing promise for one of the most common causes of blindness. Data presented today shows that six patients with wet age-related macular degeneration (AMD) have, so far, gone at least six months without the need for continued injections to control a disease that typically requires treatment every four to six weeks. Researchers say the hope is that gene therapy will free patients from nearly monthly eye injections by offering a potential "one-and-done" treatment. It's not just about convenience; a more consistent treatment may also help people keep more of their vision.
Interesting article: In-office gene therap... - Macular Society
Interesting article: In-office gene therapy for wet age-related macular degeneration is coming
That would be fantastic but not sure if it would work on my macular oedema
Hi Koalajane; Are you receiving anti-VEGF injections as part of your treatment? The idea of the gene therapy is to cause the eye to create its own anti-VEGF thereby eliminating the need for regular anti-VEGF injections. I really believe that we are on the verge of some incredible treatments and cures regarding MD and other various retinal/macular diseases. Take care! Edman
This is really great Edman but usually when something like this is announced, we usually get the words about it not being available for another ten years yet. It will be fantastic if we get it within the next year or two but I'm not holding my breath. It's in the pipeline though so that's exciting. Thanks for sharing it. x
I receive Eylea injections in my left eye once a month. I have gotten use to it now but not to get the injections would be a blessing. I pray that there is a cure soon, in my lifetime. Thank you for the information.